These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5382331)

  • 1. [The immunologic reactivity of mice with the ascitic form of Ehrlich carcinoma].
    Botev B; Markholev L
    Biull Eksp Biol Med; 1969 Dec; 68(12):70-1. PubMed ID: 5382331
    [No Abstract]   [Full Text] [Related]  

  • 2. Study on immunological reactivity of mice treated with antigen from ascitic form of Ehrlich carcinoma.
    Botev B; Marholev L; Zaharieva E; Golemanova E
    C R Acad Bulg Sci; 1970; 23(4):455-6. PubMed ID: 4919478
    [No Abstract]   [Full Text] [Related]  

  • 3. Study on the immunological reactivity of mice with solid Ehrlich adenocarcinoma.
    Botev B; Marholev L
    C R Acad Bulg Sci; 1970; 23(4):451-3. PubMed ID: 4919477
    [No Abstract]   [Full Text] [Related]  

  • 4. A kinetic aspect of the antibody production against Ehrlich tumor cells in mice bearing Ehrlich solid tumor.
    Kaneko Y; Nitta K; Umezawa H
    Gan; 1975 Oct; 66(5):573-5. PubMed ID: 1220993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of the Ehrlich ascitic fluid on the in vitro polyclonal differentiation of murine lymphocytes.
    Olinescu A; Hristescu S
    Arch Roum Pathol Exp Microbiol; 1982; 41(2):157-65. PubMed ID: 7149962
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of splenectomy on the regression of transplantable tumors.
    Ferrer JF; Mihich E
    Cancer Res; 1968 Jun; 28(6):1116-20. PubMed ID: 5658442
    [No Abstract]   [Full Text] [Related]  

  • 7. Natural cell-mediated cytotoxicity in Ehrlich ascites tumor-bearing mice.
    Olinescu A; Hristescu S; Mazilu E
    Neoplasma; 1983; 30(2):147-52. PubMed ID: 6843720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tween 80 and immunological defense against Ehrlich's ascitic carcinoma].
    Castagnone Prati D; Di Roberto F; Ingrami A
    Arch Ital Patol Clin Tumori; 1967; 10(1):29-35. PubMed ID: 5600139
    [No Abstract]   [Full Text] [Related]  

  • 9. [The influence of an anabolic hormone (dimethazine) on the immunological state of the mouse toward Ehrlich's ascitic carcinoma].
    Bonmassar E; Melan F; Montagnani-Marelli A
    Arch Ital Patol Clin Tumori; 1967; 10(1):37-40. PubMed ID: 5600140
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on inhibitory effect of homologous spleen cells on Ehrlich ascites tumor and Yoshida sarcoma.
    Soeda M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1967 Feb; 26(11):1471-82. PubMed ID: 5231926
    [No Abstract]   [Full Text] [Related]  

  • 11. Suppression of cell-mediated immunity through immune spleen cells against Ehrlich ascites tumor.
    Okubo S
    Nagoya J Med Sci; 1971 Mar; 33(4):329-40. PubMed ID: 5554418
    [No Abstract]   [Full Text] [Related]  

  • 12. Immune reactions in Ehrlich ascites tumour-bearing mice.
    Olinescu A; Babeş S; Piţur I
    Arch Roum Pathol Exp Microbiol; 1980; 39(3):249-57. PubMed ID: 7018456
    [No Abstract]   [Full Text] [Related]  

  • 13. Augmentation of in vivo antitumour activity of xenogeneic antiserum by autotransplanted normal spleen cells in mice.
    Jakóbisiak M; Kańtoch M; Lasek W; Rozmysłowicz T; Obłakowski P; Dobaczewska H
    Eur J Cancer (1965); 1981 Jan; 17(1):77-80. PubMed ID: 7262149
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunological responses of the Ehrlich tumor bearing mice of various stages (author's transl)].
    Kato T
    Nihon Ketsueki Gakkai Zasshi; 1975 Oct; 38(5):564-70. PubMed ID: 1243727
    [No Abstract]   [Full Text] [Related]  

  • 15. [Phytohaemagglutinin (PHA) induced cytotoxicity II: The effect of PHA stimulated spleen cells to Erlich tumor cells in vivo (author's transl)].
    Aoki S
    Nihon Hinyokika Gakkai Zasshi; 1978 Nov; 69(11):1404-11. PubMed ID: 739705
    [No Abstract]   [Full Text] [Related]  

  • 16. [Radiotherapy and immune reactions of spleen cells in experimental tumors].
    Juliani G; Cirillo R; Ballaira L; Fava C
    Minerva Radiol; 1969 Nov; 14(11):494-8. PubMed ID: 5383669
    [No Abstract]   [Full Text] [Related]  

  • 17. Augmentation of antitumour activity of xenogeneic antiserum by normal xenogeneic spleen cells in mice.
    Dobaczewska H; Lasek W; Marczak M; Obłakowski P; Jakóbisiak M
    Folia Biol (Krakow); 1981; 29(1):77-81. PubMed ID: 7238955
    [No Abstract]   [Full Text] [Related]  

  • 18. [The course of mammary carcinoma. New immunopathologic parameters of evaluation. Experimental study in mice (MuMT). IV. Correlation of blood picture, splenogram and ascitic fluid cells].
    Behmer OA; Zanotto A; de Tolosa EM; Gomes DM
    Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(2):44-8. PubMed ID: 3441726
    [No Abstract]   [Full Text] [Related]  

  • 19. Cellular antibody in mice bearing Ehrlich cancer. I. A quantitative study on antitumor activity of cellular antibody in vitro.
    Hara S
    Acta Med Okayama (1952); 1965 Apr; 19(2):91-8. PubMed ID: 4221891
    [No Abstract]   [Full Text] [Related]  

  • 20. [The role of serum humoral factors in metastasis and recurrence of Ehrlich carcinoma in mice].
    Donenko FV; Sitdikova SM; Moroz LV
    Biull Eksp Biol Med; 1997 Oct; 124(10):443-5. PubMed ID: 9410180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.